• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从药物诱导的肝损伤的动物模型中我们了解到了什么?

What have we learned from animal models of idiosyncratic, drug-induced liver injury?

机构信息

Department of Pharmacology and Toxicology and Institute for Integrative Toxicology, Michigan State University , East Lansing, MI, USA.

出版信息

Expert Opin Drug Metab Toxicol. 2020 Jun;16(6):475-491. doi: 10.1080/17425255.2020.1760246. Epub 2020 May 4.

DOI:10.1080/17425255.2020.1760246
PMID:32324077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7315440/
Abstract

INTRODUCTION

Idiosyncratic, drug-induced liver injury (IDILI) continues to plague patients and restrict the use of drugs that are pharmacologically effective. Mechanisms of IDILI are incompletely understood, and a better understanding would reduce speculation and could help to identify safer drug candidates preclinically. Animal models have the potential to enhance knowledge of mechanisms of IDILI.

AREAS COVERED

Numerous hypotheses have emerged to explain IDILI pathogenesis, many of which center on the roles of the innate and/or adaptive immune systems. Animal models based on these hypotheses are reviewed in the context of their contributions to understanding of IDILI and their limitations.

EXPERT OPINION

Animal models of IDILI based on an activated adaptive immune system have to date failed to reproduce major liver injury that is of most concern clinically. The only models that have so far resulted in pronounced liver injury are based on the multiple determinant hypothesis or the inflammatory stress hypothesis. The liver pathogenesis in IDILI animal models involves various leukocytes and immune mediators such as cytokines. Insights from animal models are changing the way we view IDILI pathogenesis and are leading to better approaches to preclinical prediction of IDILI potential of new drug candidates.

摘要

简介

特发性、药物诱导的肝损伤(IDILI)持续困扰着患者,并限制了具有药理作用的药物的使用。IDILI 的机制尚不完全清楚,更好地了解这些机制可以减少猜测,并有助于在临床前阶段识别更安全的药物候选物。动物模型有可能增强对 IDILI 机制的认识。

涵盖领域

已经出现了许多解释 IDILI 发病机制的假说,其中许多假说都集中在先天和/或适应性免疫系统的作用上。本文根据这些假说,对基于这些假说的动物模型进行了综述,探讨了它们对 IDILI 理解的贡献及其局限性。

专家意见

基于激活的适应性免疫系统的 IDILI 动物模型迄今为止未能复制临床上最令人关注的主要肝损伤。迄今为止,唯一导致明显肝损伤的模型是基于多决定因素假说或炎症应激假说。IDILI 动物模型中的肝脏发病机制涉及各种白细胞和免疫介质,如细胞因子。动物模型的研究结果正在改变我们对 IDILI 发病机制的看法,并为新药候选物的 IDILI 潜在风险的临床前预测提供了更好的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/128444013ee7/nihms-1588726-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/6ab12e70e003/nihms-1588726-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/bcf16529975a/nihms-1588726-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/4ac5ffcf94d4/nihms-1588726-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/cd42152777d6/nihms-1588726-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/bd145e6b37ea/nihms-1588726-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/8b3197642cd3/nihms-1588726-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/8297981f1a6b/nihms-1588726-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/21e69c48f064/nihms-1588726-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/128444013ee7/nihms-1588726-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/6ab12e70e003/nihms-1588726-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/bcf16529975a/nihms-1588726-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/4ac5ffcf94d4/nihms-1588726-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/cd42152777d6/nihms-1588726-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/bd145e6b37ea/nihms-1588726-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/8b3197642cd3/nihms-1588726-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/8297981f1a6b/nihms-1588726-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/21e69c48f064/nihms-1588726-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/510a/7315440/128444013ee7/nihms-1588726-f0009.jpg

相似文献

1
What have we learned from animal models of idiosyncratic, drug-induced liver injury?从药物诱导的肝损伤的动物模型中我们了解到了什么?
Expert Opin Drug Metab Toxicol. 2020 Jun;16(6):475-491. doi: 10.1080/17425255.2020.1760246. Epub 2020 May 4.
2
Animal models of idiosyncratic drug-induced liver injury--current status.特发性药物性肝损伤的动物模型——现状。
Crit Rev Toxicol. 2011 Oct;41(9):723-39. doi: 10.3109/10408444.2011.575765. Epub 2011 Jul 4.
3
Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.特发性药物性肝损伤:机制和临床挑战。
Int J Mol Sci. 2021 Mar 14;22(6):2954. doi: 10.3390/ijms22062954.
4
Mechanisms of idiosyncratic drug-induced liver injury.特异质性药物性肝损伤的机制
Adv Pharmacol. 2019;85:133-163. doi: 10.1016/bs.apha.2018.12.001. Epub 2019 Jan 18.
5
The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury.定量系统药理学建模在预测和解释特异质性药物性肝损伤中的作用。
Drug Metab Pharmacokinet. 2017 Feb;32(1):40-45. doi: 10.1016/j.dmpk.2016.11.008. Epub 2016 Nov 21.
6
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.特异质性药物性肝损伤(iDILI)的临床前模型:迈向预测
Acta Pharm Sin B. 2021 Dec;11(12):3685-3726. doi: 10.1016/j.apsb.2021.11.013. Epub 2021 Nov 18.
7
Immune mechanisms of idiosyncratic drug-induced liver injury.特异质性药物性肝损伤的免疫机制
J Clin Transl Res. 2017 Feb 12;3(1):145-156. eCollection 2017 Feb 17.
8
Liver Injury Caused by Green Tea Extract in PD-1 Mice: An Impaired Immune Tolerance Model for Idiosyncratic Drug-Induced Liver Injury.绿茶提取物致 PD-1 小鼠肝损伤:一种用于特发性药物性肝损伤的免疫耐受受损模型。
Chem Res Toxicol. 2021 Mar 15;34(3):849-856. doi: 10.1021/acs.chemrestox.0c00485. Epub 2021 Feb 22.
9
Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.编辑重点:免疫耐受受损动物模型区分曲格列酮/吡格列酮和托卡朋/恩他卡朋引起 IDILI 的潜力。
Toxicol Sci. 2018 Feb 1;161(2):412-420. doi: 10.1093/toxsci/kfx219.
10
Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.利用大鼠肝基因表达的因果推理来鉴定药物性肝损伤的分子途径。
Toxicol Sci. 2014 Jan;137(1):234-48. doi: 10.1093/toxsci/kft232. Epub 2013 Oct 17.

引用本文的文献

1
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology.用于预测毒理学的人体肝脏芯片的性能评估与经济分析。
Commun Med (Lond). 2022 Dec 6;2(1):154. doi: 10.1038/s43856-022-00209-1.
2
Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury.特发性、药物性肝损伤的药代动力学和毒代动力学概念。
Expert Opin Drug Metab Toxicol. 2022 Jul-Aug;18(7-8):469-481. doi: 10.1080/17425255.2022.2113379. Epub 2022 Aug 24.

本文引用的文献

1
Mechanistic Studies of Idiosyncratic DILI: Clinical Implications.特异质性药物性肝损伤的机制研究:临床意义
Front Pharmacol. 2019 Jul 26;10:837. doi: 10.3389/fphar.2019.00837. eCollection 2019.
2
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor.免疫检查点抑制剂所致胃肠道毒性的管理
GE Port J Gastroenterol. 2019 Jul;26(4):268-274. doi: 10.1159/000494569. Epub 2018 Dec 17.
3
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity.预防性肿瘤坏死因子阻断对双重程序性死亡受体-1和细胞毒性T淋巴细胞相关抗原4免疫疗法疗效及毒性的影响
Cell Stress. 2019 Jun 27;3(7):236-239. doi: 10.15698/cst2019.07.193.
4
Mechanisms of idiosyncratic drug-induced liver injury.特异质性药物性肝损伤的机制
Adv Pharmacol. 2019;85:133-163. doi: 10.1016/bs.apha.2018.12.001. Epub 2019 Jan 18.
5
Hepatotoxicity of immune check point inhibitors: Approach and management.免疫检查点抑制剂的肝毒性:方法与管理。
Dig Liver Dis. 2019 Aug;51(8):1074-1078. doi: 10.1016/j.dld.2019.06.017. Epub 2019 Jul 8.
6
Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control.接受检查点阻断治疗后的结肠炎:需入院接受症状控制治疗的黑色素瘤患者的回顾性队列研究。
Cancer Med. 2019 Sep;8(11):4986-4999. doi: 10.1002/cam4.2397. Epub 2019 Jul 9.
7
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.免疫检查点抑制剂的不良反应:流行病学、管理和监测。
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580. doi: 10.1038/s41571-019-0218-0.
8
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.卡马西平诱导超敏反应的共享遗传风险因素。
Clin Pharmacol Ther. 2019 Nov;106(5):1028-1036. doi: 10.1002/cpt.1493. Epub 2019 Jul 3.
9
Animal models of drug-induced liver injury.药物性肝损伤的动物模型。
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):1031-1039. doi: 10.1016/j.bbadis.2018.08.037. Epub 2018 Sep 3.
10
HLA-B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum-Induced Liver Injury in Humans.HLA-B*35:01 等位基因是预测人类何首乌肝损伤的潜在生物标志物。
Hepatology. 2019 Jul;70(1):346-357. doi: 10.1002/hep.30660. Epub 2019 May 21.